UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 20-F/A

(Amendment No. 1)



| |  ̈ | REGISTRATION STATEMENT
PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | ----------------------------------------------------------------------------------------------



OR



| | x | ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | ------------------------------------------------------------------------------------



For
the fiscal year ended December 31, 2017

OR



| |  ̈ | TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | ----------------------------------------------------------------------------------------



For
the transition period from ___________ to ___________ __________



OR



| |  ̈ | SHELL
COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | - | -------------------------------------------------------------------------------------------



Date
of event requiring this shell company report



Commission file number: 333-207107



EHAVE,
INC

(Exact name of Registrant as specified in
its charter

and translation of Registrant’s name
into English)



Canada

(Jurisdiction of incorporation or organization)



203-277 Lakeshore Road East

Oakville, Ontario, Canada L6J 6J3

(Address of principal executive offices)



Prateek Dwivedi, Chief Executive Officer

203-277 Lakeshore Road East

Oakville, Ontario, Canada L6J 6J3

+1(905) 362-1499

info@ehave.com

(Name, Telephone, E-mail and/or Facsimile
number and Address of Company Contact Person)



Securities registered pursuant to Section
12(b) of the Act: None



Securities registered pursuant to Section
12(g) of the Act: Common Shares, no par value



Securities for which there is a reporting
obligation pursuant to Section 15(d) of the Act:  None



Indicate the number of outstanding shares
of each of the Registrant’s classes of capital or common stock as of the close of the period covered by the annual report:
71,304,035 common shares as at December 31, 2017



Indicate by check mark if the registrant
is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ̈
No x



If this report is an annual or transition
report, indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934. Yes  ̈ No x



Indicate by check mark whether the Registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes x No  ̈



Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files).  Yes x
No  ̈



Indicate by check mark whether the Registrant
is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or an emerging growth company.  See definition
of “accelerated filer and large accelerated filer,” and "emerging growth company" in Rule 12b-2 of the Exchange
Act.  (Check one)



|Large accelerated filer  ̈ | Accelerated filer  ̈ | Non-accelerated filer x | Emerging growth company x
|------------------------- | ------------------- | ----------------------- | -------------------------



If an emerging growth company that prepares
its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a)
of the Exchange Act.  ̈



† The term “new or revised
financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting
Standards Codification after April 5, 2012.



Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing:



|US GAAP | International Financial Reporting Standards as issued  by the International Accounting Standards Board | Other
|------- | ------------------------------------------------------------------------------------------------------ | -----
|x       |  ̈                                                                                                      |  ̈    



If “Other” has been checked
in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:



|Item 17  ̈ | Item 18  ̈
|--------- | ---------



If this is an annual report, indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes  ̈No x


















EXPLANATORY
NOTE



We are
filing this Amendment No. 1 to our Annual Report on Form 20-F for the year ended December 31, 2017, which was
originally filed with the Securities and Exchange Commission (the “Commission”) on June 14, 2018 (the
 “Original Filing”), solely to amend Item 7.A  “Major Shareholders” in the percentage and number
of our shares beneficially owned by David Stefansky. This Amendment No. 1 amends and restates “Item 7. Major
Shareholders and Related Party Transactions” of Part I of the Original Report. In the Original Report, we reported that
David Stefansky beneficially owned 8,801,176 shares, or 12.17%, of our common shares outstanding as of May 14, 2018, in the
table of major shareholders (and footnote (1) thereto) and under “Changes in Percentage Ownership by
Major Shareholders,” when it should be 7,612,477 shares, or 9.99% of our common shares outstanding as of May 14,
2018, excluding 1,188,697 common shares that may be purchased by Bezalel Partners, LLC over which Mr. Stefansky has sole
voting and dispositive power upon exercise of certain warrants which contain provisions that block exercise if such exercise
will result in the holder having beneficial ownership of more than 9.99% of our outstanding common shares. This amendment has
no effect on, and has not resulted in any changes to, the Company’s audited financial statements or the notes thereto
for the year ended December 31, 2017, as previously reported in the Original Report.



Pursuant to the rules of the Commission,
Item 19 has been updated to include the certifications of the Chief Executive Officer and the Chief Financial Officer in connection
with this Amendment No. 1 to the Original Filing.



Other than
as expressly set forth above, this Form 20-F/A does not, and does not purport to, amend, update or restate the information in
any other item of the Original Report, or reflect any events that have occurred after the Original Report was originally
filed. Except for the revision to Item 7 and the new certifications filed herewith, no other changes have been made to the
Original Report. The other information in the Original Report continues to speak as of the date of the Original Report, and
we have not updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the filing
of the Original Report. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing and our
Reports on Form 6-K that are subsequent to the filing of the Original Report.



EHAVE INC.



FORM 20-F



TABLE OF CONTENTS



|Item 7.    | Major Shareholders and Related Party Transactions | 3
|---------- | ------------------------------------------------- | -
|Item 19.   | Exhibits                                          | 7
|Signatures | 10                                               



2









ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS



| | A. | Major Shareholders
| | -- | ------------------



The following table lists the beneficial
ownership of our securities as of May 14, 2018, by each person known by us to be the beneficial owner of 5% or more of the outstanding
shares of any class of our securities. As of May 14, 2018, 71,304,035 of our ordinary shares were outstanding. As at May 14, 2018,
with the exception of Shareholders disclosed in “Item 6.E Share Ownership”, we are not aware of any shareholder who
beneficially owns, directly or indirectly, or exercises control or direction over, our common shares, of more than 5% of the outstanding
common shares.



|Name of Beneficial Owner            |  | Number of Shares Beneficially Owned |           |  | Percentage of Shares Outstanding | 
|----------------------------------- |  | ----------------------------------- | --------- |  | -------------------------------- | 
|Rocfrim, Inc. (2)(3)(4)             |  |                                     | 7,840,882 |  |                                  | 
|                                    |  |                                     |           |  |                                  | 
|Plazacorp Investments Limited(5)(6) |  |                                     | 8,601,992 |  |                                  | 
|                                    |  |                                     |           |  |                                  | 
|David Stefansky (1)                 |  |                                     | 7,612,477 |  |                                  | 
|                                    |  |                                     |           |  |                                  | 
|Eisenberg Family Foundation(7)      |  |                                     | 9,088,710 |  |                                  | 








|(1) | Includes (i) 3,716,381 common shares, (ii) 988,206 common shares issuable upon the conversion of notes and (iii) 2,907,890 common shares issuable upon the exercise of warrants that are currently convertible or exercisable within 60 days of May 14, 2018, beneficially owned by Mr. Stefansky and Bezalel Partners, LLC over which Mr. Stefansky has sole voting and dispositive power. Does not include 1,188,697 common shares that may be purchased by Bezalel Partners, LLC over which Mr. Stefansky has sole voting and dispositive power upon exercise of certain warrants. These common shares are excluded because these warrants contain provisions that block exercise if such exercise will result in the holder having beneficial ownership of more than 9.99% of our outstanding common shares.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(2) | Includes 872,870 shares issuable upon the exercise of warrants that are currently exercisable within 60 days of May 14, 2018 and 872,870 shares issuable upon the conversion of the convertible note outstanding as of May 14, 2018.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
|(3) | Includes (i) 697,248 shares held by Rocpart Inc. ("Rocpart") over which Mr. Kaplan, as President of Rocpart has sole voting and dispositive power and (ii) 5,476,772 shares held by Rocfrim over which Mr. Kaplan has sole voting and dispositive power.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
|(4) | Jesse Kaplan, President of Rocfrim has sole voting and dispositive power over shares held by Rocfrim.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|(5) | Sruli Weinrib, Vice President of Plazacorp has sole voting and dispositive power over shares held by Plazacorp.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
|(6) | Includes 888,615 shares issuable upon the exercise of warrants that are currently exercisable within 60 days of May 14, 2018 and 888,615 shares issuable upon the conversion of the convertible note outstanding as of May 14, 2018.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
|(8) | Solomon Eisenberg has sole voting and dispositive power over shares held by Eisenberg Family Foundation. Includes 4,544,355 shares issuable upon the conversion of the convertible note outstanding as of May 14, 2018.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         



The voting rights of our major shareholders
do not differ from the voting rights of holders of our shares who are not major shareholders. Each of the above listed securities
entitles the holder to one vote at our company’s shareholder meetings.



Changes in Percentage Ownership by
Major Shareholders



As of May 14, 2018, Mr. Woodrow, a founder
of the Company, beneficially owned 19,777,338 common shares, or 27.73%, of our then outstanding common shares.



As of May 15, 2017, Mr. Woodrow beneficially
owned 19,777,338 common shares, or 27.73%, of our then outstanding common shares.



As of March 10, 2016, Mr. Woodrow beneficially
owned 19,777,241 common shares, or 63.24%, of our then outstanding common shares.



3









As of March 10, 2016, Romena Holdings Inc.
beneficially owned 5,000,000 common shares, or 17.81%, of our then outstanding common shares.



As of May 14, 2018, Rocfrim Inc. beneficially
owned 7,840,882 common shares, or 10.84%, of our then outstanding common shares.



As of May 15, 2017, Rocfrim Inc. beneficially
owned 7,449,646 common shares, or 9.6%, of our then outstanding common shares.



As of March 10, 2016, Rocfrim Inc. beneficially
owned 5,476,772 common shares, or 16.32% of our then outstanding common shares.



As of May 14, 2018, Plazacorp Investments
Limited beneficially owned 8,601,992 common shares, or 11.9%, of our then outstanding common shares.



As of May 15, 2017, Plazacorp Investments
Limited beneficially owned 7,567,951 common shares, or 9.84%, of our then outstanding common shares.



As of March 10, 2016, Plazacorp Investments
Limited beneficially owned 5,476,772 common shares, or 16.32% of our then outstanding common shares.



As of May 14, 2018, David Stefansky beneficially
owned 7,612,477 common shares, or 9.99%, of our then outstanding common shares. Does not include 1,188,697 common shares that may
be purchased by Bezalel Partners, LLC over which Mr. Stefansky has sole voting and dispositive power upon exercise of certain warrants.
These common shares are excluded because these warrants contain provisions that block exercise if such exercise will result in
the holder having beneficial ownership of more than 9.99% of our outstanding common shares.



As of May 15, 2017, David Stefansky beneficially
owned 7,567,951 common shares, or 9.84%, of our then outstanding common shares. Includes 5,590,791 common shares and shares issuable
upon exercise of warrants beneficially owned by Bezalel Partners, LLC over which Mr. Stefansky has sole voting and dispositive
power.



As of March 10, 2016, David Stefansky beneficially
owned 7,546,781 common shares, or 9.81% of our then outstanding common shares.



As of May 14, 2018, Eisenberg Family Foundation
beneficially owned 9,088,710 common shares, or 12.57%, of our then outstanding common shares. Solomon Eisenberg has sole voting
and dispositive power over shares held by Eisenberg Family Foundation.



Shares Held in the United States



The following table indicates, as of May
14, 2018, the total number of common shares issued and outstanding, the approximate total number of holders of record of common
shares, the number of holders of record of common shares with U.S. addresses, the portion of the outstanding common shares
held by U.S. holders of record, and the percentage of common shares held by U.S. holders of record. This table does not
indicate beneficial ownership of common shares.



|Total Number of Holders of Record |  | Total Number of Common Shares Issued and Outstanding |            |  | Number of US Holders of Record |  |    | Number of Common Shares Held by US Holders of Record |  |  | Percentage of Common Shares Held by US Holders of Record | 
|--------------------------------- |  | ---------------------------------------------------- | ---------- |  | ------------------------------ |  | -- | ---------------------------------------------------- |  |  | -------------------------------------------------------- | 
|48                                |  |                                                      | 71,304,035 |  |                                |  | 11 |                                                      |  |  | 34,027,278                                               | 



Change of Control



As of May 14, 2018, there were no arrangements
known to the Company which may, at a subsequent date, result in a change of control of the Company.



Control by Others



To the best of the Company’s knowledge, the Company is
not directly or indirectly owned or controlled by another corporation, any foreign government, or any other natural or legal person,
severally or jointly.





4









| | B. | Related Party Transactions
| | -- | --------------------------



Other than the transactions described below,
since January 1, 2017, we entered into related party transactions as follows:



| | · | We have entered into employment contracts with each of our officers (see Item 6).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
| | - | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | · | We entered into an Investor Letter, dated October 11, 2017, with each of Scott Woodrow, Jesse Kaplan, PlazaCorp Investments Limited, Rocfrim Inc., Bezalel Partners LLC, and David Stefansky, pursuant to which such persons agreed to purchase securities of the Company on similar terms as certain offerings of the Company that are consummated prior to December 31, 2017, or, if such an offering is not consummated, the purchase amount will be converted into a secured promissory note that matures on January 31, 2018 (which, at the investor’s option, may be converted into common shares of the Company). Such investors are also entitled to additional warrant coverage in the event that we do not close such an offering prior to December 31, 2017. No such offering consummated prior to December 31, 2017, and such notes were converted into unsecured convertible debentures notes on January 31, 2018.
| | · | On July 27, 2017, the Company entered into a demand non-interest bearing secured promissory note with Scott Woodrow, a director of the Company, in the principal amount of $47,778 (CDN$60,000). In November 2017, the note was converted into a note with 626,513 attached warrants. Subsequently, the note has been repaid.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
| | · | On July 27, 2017, the Company entered into a demand non-interest bearing secured promissory note with NView Management in the principal amount of $86,797 (CDN$109,000). Scott Woodrow, a director of the Company, is the controlling shareholder, director and President of NView Management, Currently, $45,490 (CDN$59,000) is outstanding on this note.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    



| | · | On October 11, 2017, the Company entered into a demand non-interest bearing unsecured promissory note with Scott Woodrow, a director of the Company, in the principal amount of $80,276 (CDN$100,000). On January 18, 2018 the note was exchanged for an unsecured convertible debenture.
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



5









| | · | We entered into a term sheet with Companion Healthcare Corporation (“CHC”), dated June 30, 2017, whereby CHC will acquire the exclusive rights to the Company’s informatics platform for use in companion animals, and we received a deposit of $135,232 for the Company’s fieldwork. License fees are to be established by a third party evaluator. Scott Woodrow, a director of the Company, is the President and a minority shareholder of CHC.                                                                                                                                                                                                                                                                                                                                                        
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | · | On November 14, 2016, we entered into a definitive securities purchase agreement to sell up to $1,500,026 of convertible promissory notes and warrants in multiple closings in a private placement. Each of Bezalel Partners, LLC (an entity over which Mr. Stefansky holds sole control), Rocfrim, Inc. and Plazacorp Investments Limited participated in the private placement committed to fund a total of $185,718 per such investor. As of May 14, 2018, Bazalel Partners, LLC has purchased convertible promissory notes in an aggregate principal amount of $55,358, Rocfrim, Inc. has purchased convertible promissory notes in an aggregate principal amount of $48,897 and Plazacorp Investments Limited has purchased convertible promissory notes in an aggregate principal amount of $49,779.



| | C. | Interests of Experts and Council
| | -- | --------------------------------



Not applicable





6









ITEM 19. EXHIBITS.



The following exhibits are filed as part of this annual report:





|ExhibitNumber |  | Description                                                                                                                     
|------------- |  | --------------------------------------------------------------------------------------------------------------------------------
|              |  |                                                                                                                                 
|1.1           |  | Articles of Incorporation (1)                                                                                                   
|1.2           |  | Articles of Amendment to the Articles of Incorporation dated November 30, 2011 (2)                                              
|1.3           |  | Articles of Amendment to the Articles of Incorporation dated May 13, 2015 (3)                                                   
|1.4           |  | Articles of Amendment to the Articles of Incorporation dated June 26, 2015 (4)                                                  
|1.5           |  | Articles of Amendment to the Articles of Incorporation dated November 4, 2015 (5)                                               
|1.6           |  | Bylaws No. 2 (6)                                                                                                                
|4.1           |  | Form of Convertible Loan Agreement (7)                                                                                          
|4.2           |  | Securities Purchase Agreement, dated July 7, 2015, between the Company and the purchasers identified therein (8)                
|4.3           |  | Form of Secured Convertible Note, dated July 7, 2015 (9)                                                                        
|4.4           |  | Form of Common Stock Purchase Warrant, dated July 7, 2015 (10)                                                                  
|4.5           |  | Form of Lock Up Agreement (11)                                                                                                  
|4.6           |  | License Agreement, dated April 24, 2015, between the Company and The Governing Counsel of the University of Toronto (12)        
|4.7           |  | Form of Subscription Agreement (13)                                                                                             
|4.8           |  | Office Suite License and Services Agreement, effective November 1, 2015, between iQ Univeristy LP and the Company (14)          
|4.9           |  | Form of Warrant sold in the registered public offering (15)                                                                     
|4.10          |  | Services Agreement, dated February 1, 2016 with Artimetrix Software Inc. (16)                                                   
|4.11          |  | Consulting Agreement, dated August 3, 2015 with 8121346 Canada Inc. (17)                                                        
|4.12          |  | Amendment to Consulting Agreement, dated February 1, 2016 with 8121346 Canada Inc. (18)                                         
|4.13          |  | Master Services Agreement, dated December 8, 2015 with Blog Inc LLC (dba Cress & Company) (19)                                  
|4.14          |  | Executive Employment Agreement, dated July 25, 2016, between the Company and its President and CEO, Prateek Dwivedi (20)        
|4.15          |  | Executive Employment Agreement, dated December 1, 2016, between the Company and its Chief Technology Officer, David Goyette (21)
|4.16          |  | Offer to Sublease, dated January 30, 2017, between the Company and Home Trust Company (22)                                      
|4.17          |  | API Integration & Distribution Agreement dated December 13, 201,6 between the Company and MHS (23)                              
|4.18          |  | Letter of Agreement, dated November 1, 2017, between the Company and Tiberend Strategic Advisors, Inc. (24)                     
|4.19          |  | Stock Option Plan, approved on January 12, 2017, at the Annual and Special Meeting of Shareholders (25)                         
|4.20          |  | Note and Warrant Purchase Agreement, dated as of November 14, 2016 (26)                                                         
|4.21          |  | Form of Convertible Promissory Note (27)                                                                                        
|4.22*         |  | Strategic Relationship Agreement, dated as of February 3, 2017, between the Company and MedReleaf Corp.                         
|4.23*         |  | Amendment to API Integration & Distribution Agreement, dated as of May 4, 2017, between the Company and MHS                     
|4.24*         |  | Form of Promissory Note                                                                                                         
|4.25*         |  | Form of Investor Letter                                                                                                         
|4.26*         |  | Form of Promissory Note with Warrants                                                                                           
|4.27*         |  | Form of Secured Subscription Agreement for Units                                                                                
|4.28*         |  | Form of Compensation Option to Purchase Common Shares                                                                           
|4.29*         |  | Form of Senior Secured Convertible Debenture                                                                                    
|4.30*         |  | Form of Warrant to Purchase Common Shares                                                                                       
|4.31*         |  | Form of Unsecured Subscription Agreement for Units (Premium)                                                                    
|4.32*         |  | Form of Unsecured Subscription Agreement for Units (Regular)                                                                    
|4.33*         |  | Form of Unsecured Convertible Debenture                                                                                         
|4.34*         |  | Agreement, dated March 1, 2018, between the Company and Revive Therapeutics Ltd.                                                
|4.35*         |  | Agreement, dated March 5, 2018, between the Company and Aequus Pharmaceuticals Inc.                                             
|4.36*         |  | Services Agreement, dated January 15, 2017, between the Company and NView Management Inc.                                       
|4.37*         |  | Services Agreement, dated April 23, 2018, between the Company and Dianne Parsons, C.P.A.                                        





7







|4.38*    |  | Lease, dated April 6, 2018, between the Company and Lisgar Development Limited                      
|-------- |  | ----------------------------------------------------------------------------------------------------
|12.1     |  | Certificate of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|12.2     |  | Certificate of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|13.1     |  | Certificate of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|13.2     |  | Certificate of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|101.INS* |  | XBRL Instance Document                                                                              
|101.SCH* |  | XBRL Taxonomy Extension Schema Document                                                             
|101.CAL* |  | XBRL Taxonomy Extension Calculation Linkbase Document                                               
|101.DEF* |  | XBRL Taxonomy Extension Definition Linkbase Document                                                
|101.LAB* |  | XBRL Taxonomy Extension Label Linkbase Document                                                     
|101.PRE* |  | XBRL Taxonomy Extension Presentation Linkbase Document                                              



*Previously filed or furnished














|(1)  | Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.  
|---- | -----------------------------------------------------------------------------------------------------------------------------------------
|(2)  | Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.  
|(3)  | Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.  
|(4)  | Incorporated by reference to Exhibit 3.4 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.  
|(5)  | Incorporated by reference to Exhibit 3.6 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.  
|(6)  | Incorporated by reference to Exhibit 3.5 to the Form 6-K filed with the SEC on January 12, 2017.                                         
|(7)  | Incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form F-1 filed with the SEC on September 24, 2015.  
|(8)  | Incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form F-1 filed with the SEC on September 24, 2015.  
|(9)  | Incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form F-1 filed with the SEC on September 24, 2015.  
|(10) | Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form F-1 filed with the SEC on September 24, 2015.  
|(11) | Incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form F-1 filed with the SEC on September 24, 2015.  
|(12) | Incorporated by reference to Exhibit 10.9 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015. 
|(13) | Incorporated by reference to Exhibit 10.19 to the Company’s Registration Statement on Form F-1/A filed with the SEC on December 18, 2015.
|(14) | Incorporated by reference to Exhibit 10.21 to the Company’s Registration Statement on Form F-1/A filed with the SEC on November 16, 2015.
|(15) | Incorporated by reference to Exhibit 10.23 to the Company’s Registration Statement on Form F-1/A filed with the SEC on December 18, 2015.
|(16) | Incorporated by reference to Exhibit 10.24 to the Company’s Registration Statement on Form F-1/A filed with the SEC on March 11, 2016.   
|(17) | Incorporated by reference to Exhibit 10.25 to the Company’s Registration Statement on Form F-1/A filed with the SEC on March 11, 2016.   
|(18) | Incorporated by reference to Exhibit 10.26 to the Company’s Registration Statement on Form F-1/A filed with the SEC on March 11, 2016.   
|(19) | Incorporated by reference to Exhibit 10.27 to the Company’s Registration Statement on Form F-1/A filed with the SEC on March 11, 2016.   
|(20) | Incorporated by reference to Exhibit 4.14 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.                
|(21) | Incorporated by reference to Exhibit 4.15 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.                
|(22) | Incorporated by reference to Exhibit 4.16 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.                
|(23) | Incorporated by reference to Exhibit 4.17 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.                



8









|(24) | Incorporated by reference to Exhibit 4.18 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.
|---- | -------------------------------------------------------------------------------------------------------------------------
|(25) | Incorporated by reference to Exhibit 4.19 to the Company’s Annual Report on Form 20-F filed with the SEC on May 16, 2017.
|(26) | Incorporated by reference to Exhibit 99.1 to the Form 6-K filed with the SEC on November 23, 2016.                       
|(27) | Incorporated by reference to Exhibit 99.2 to the Form 6-K filed with the SEC on November 23, 2016.                       



9







SIGNATURE



The registrant hereby
certifies that it meets all of the requirements for filing on Form 20-F/A and that it has duly caused and authorized the undersigned
to sign this annual report on its behalf.



Date: August 17, 2018



EHAVE, INC.



|/s/ Prateek Dwivedi     |  | /s/ Dianne Parsons     
|----------------------- |  | -----------------------
|Prateek Dwivedi         |  | Dianne Parsons         
|Chief Executive Officer |  | Chief Financial Officer



10